Abstract
Migraine is treated with many preventative and acute therapies. A stepwise approach should be used to limit spending with cost effective evidence-driven therapies. The high cost of Botulinum Toxin (BT) leads to fears of misuse due to similar route of administration to cosmetic application. Little is known about differences in demographics and costs between migraineurs using BT to those who do not.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
